EB
Eric Bernstein
Hematology & Oncology
Credentials: · · ·
History
- 2010–2013
Hematology and Medical Oncology
Research
OX40 is a potent immune-stimulating target in late-stage cancer patients
Cancer Research · 2013 · 396 citations
The Lancet Oncology · 2022 · 131 citations
Journal of Thoracic Oncology · 2014 · 31 citations

2 papers
- WU
2 papers

1 paper

1 paper

1 paper

1 paper
- BG
1 paper

1 paper

